Fallopian Tube High Grade Serous Adenocarcinoma

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Bevacizumab and Anetumab Ravtansine or Paclitaxel in Treating Patients With Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]

  Phase 2 clinical trial evaluating Bevacizumab in combination with Anetumab Ravtansine or Paclitaxel for refractory ovarian, fallopian tube, …

• CLINICAL_TRIALS trial_result · 2024-06-18
  Clinical Trial Update: Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents [Phase 2]

  Phase 2 study comparing standard of care versus a triplet targeted immunotherapy combination in Fallopian tube mucinous adenocarcinoma and o…